1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
Odyssey Therapeutics, Inc.

Odyssey Therapeutics, Inc.

ODTX
Odyssey Therapeutics, Inc.US flagNASDAQ Global Market
18.61
USD
+0.39
- -
562.55MMarket Cap

Income Statement (USD)

APIChatGPT
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Sales/Revenue/Turnover
- -
1
4
3
+ Sales & Services Revenue
- -
1
4
3
- Cost of Revenue
- -
- -
- -
- -
+ Cost of Goods & Services
- -
- -
- -
- -
Gross Profit
- -
- -
- -
- -
+ Other Operating Income
- -
-1
-4
-3
- Operating Expenses
123
134
140
164
+ Selling, General & Admin
21
22
27
38
+ Research & Development
102
112
113
127
+ Other Operating Expense
- -
- -
- -
- -
Operating Income (Loss)
-123
-133
-135
-161
- Non-Operating (Income) Loss
2
-8
-6
-12
+ Interest Expense, Net
-4
-8
-8
-6
+ Interest Expense
- -
- -
- -
- -
- Interest Income
4
9
8
6
+ Other Non-Op (Income) Loss
5
1
2
-5
Pretax Income
-124
-125
-129
-150
- Income Tax Expense (Benefit)
- -
- -
- -
-1
- (Income) Loss from Affiliates
- -
- -
- -
- -
Income (Loss) from Cont Ops
-125
-126
-129
-149
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
Income (Loss) Incl. MI
-125
-126
-129
-149
- Minority Interest
- -
- -
- -
- -
Net Income, GAAP
-125
-126
-129
-149
- Preferred Dividends
- -
5
1
- -
- Other Adjustments
- -
- -
- -
- -
Net Income Avail to Common, GAAP
-125
-131
-130
-149
EBIT
-123
-133
-135
-161
EBITDA
-120
-129
-130
-156
EBITDA Margin (%)
- -
-12,394.5
-2,907.65
-5,250.17
EBITA
-123
-133
-135
-161
Gross Margin (%)
- -
100
100
100
Operating Margin (%)
- -
-12,867.79
-3,023.77
-5,415.19
Profit Margin (%)
- -
-12,144.46
-2,891.79
-4,994.86
Sales per Employee
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
Depreciation Expense
3
5
5
5
Basic Weighted Avg Shares
28
99
28
28
Basic EPS, GAAP
-4.52
-1.32
-4.73
-5.39
Basic EPS from Cont Ops
-4.52
-1.27
-4.69
-5.39
Diluted Weighted Avg Shares
28
99
28
28
Diluted EPS, GAAP
-4.52
-1.32
-4.73
-5.39
Diluted EPS from Cont Ops
-4.52
-1.27
-4.69
-5.39

Balance Sheet (USD)

APIChatGPT
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Total Current Assets
249
193
136
191
+ Cash, Cash Equivalents & STI
241
187
129
181
+ Cash & Cash Equivalents
241
53
59
42
+ ST Investments
- -
134
70
140
+ Accounts & Notes Receiv
- -
- -
- -
- -
+ Accounts Receivable, Net
- -
- -
- -
- -
+ Notes Receivable, Net
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
+ Other Receivable, Net
- -
- -
- -
- -
+ Inventories
- -
- -
- -
- -
+ Raw Materials
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
+ Other ST Assets
8
6
6
9
+ Misc ST Assets
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
Total Noncurrent Assets
68
94
62
79
+ Property, Plant & Equip, Net
53
47
39
26
+ Property, Plant & Equip
55
54
51
40
- Accumulated Depreciation
2
7
11
14
+ LT Investments & Receivables
- -
29
- -
35
+ LT Investments
- -
29
- -
35
+ LT Receivables
- -
- -
- -
- -
+ Other LT Assets
16
18
22
18
+ Total Intangible Assets
14
14
14
15
+ Goodwill
13
14
13
14
+ Other Intangible Assets
1
1
1
- -
+ LT Deferred Tax Assets
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
+ Misc LT Assets
2
4
9
3
Total Assets
317
287
197
270
+ Payables & Accruals
12
10
10
14
+ Accounts Payable
8
8
6
8
+ Accrued Taxes
1
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
+ Other Payables & Accruals
3
2
4
6
+ ST Debt
3
4
5
5
+ ST Borrowings
- -
- -
- -
- -
+ ST Finance Leases
3
4
5
5
+ Other ST Liabilities
7
8
14
7
+ Deferred Revenue
1
- -
3
- -
+ Derivatives & Hedging
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
+ Misc ST Liabilities
6
7
11
7
Total Current Liabilities
23
22
28
26
+ LT Debt
39
31
26
22
+ LT Borrowings
5
- -
- -
- -
+ LT Finance Leases
34
31
26
22
+ Other LT Liabilities
400
497
525
710
+ Accrued Liabilities
- -
- -
- -
- -
+ Pension Liabilities
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
+ Misc LT Liabilities
400
497
525
710
Total Noncurrent Liabilities
439
527
552
732
Total Liabilities
462
549
580
758
+ Preferred Equity and Hybrid Capital
- -
- -
- -
- -
+ Share Capital & APIC
16
27
38
80
+ Common Stock
- -
- -
- -
- -
+ Additional Paid in Capital
16
27
38
80
- Treasury Stock
- -
- -
- -
- -
+ Retained Earnings
-158
-289
-419
-568
+ Other Equity
-2
-1
-1
- -
Equity Before Minority Interest
-145
-263
-383
-488
+ Minority/Non Controlling Interest
- -
- -
- -
- -
Total Equity
-145
-263
-383
-488
Total Liabilities & Equity
317
287
197
270
Shares Outstanding
47
47
47
47
Number of Employees
- -
- -
- -
- -
Capital Leases - Total
38
34
31
27
Net Debt
-236
-53
-59
-42
Net Debt to Equity
163.38
20
15.46
8.54
Tangible Common Equity Ratio
-52.35
-101.88
-216.02
-197.05
Current Ratio
10.91
8.72
4.77
7.2
Cash Conversion Cycle
- -
- -
- -
- -

Cash Flow Statement (USD)

APIChatGPT
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2022
12/31/2023
12/31/2024
12/31/2025
+ Net Income
-125
-126
-129
-149
+ Depreciation & Amortization
3
5
5
5
+ Non-Cash Items
23
7
10
19
+ Stock-Based Compensation
6
6
9
14
+ Deferred Income Taxes
- -
- -
- -
- -
+ Asset Impairment Charge
- -
- -
- -
5
+ Other Non-Cash Adj
17
1
1
-1
+ Chg in Non-Cash Work Cap
-1
1
-3
-5
+ (Inc) Dec in Accts Receiv
- -
- -
- -
- -
+ (Inc) Dec in Inventories
- -
- -
- -
- -
+ (Inc) Dec in Prepaid Assets
-2
2
-1
-3
+ Inc (Dec) in Accts Payable
10
1
1
-2
+ Inc (Dec) in Other
-8
-2
-4
1
+ Net Cash From Disc Ops
- -
- -
- -
- -
Cash from Operating Activities
-100
-113
-117
-129
+ Change in Fixed & Intang
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
+ Acq of Fixed & Intang
-13
-5
-1
-1
+ Acq of Fixed Prod Assets
-13
-5
-1
-1
+ Acq of Intangible Assets
- -
- -
- -
- -
+ Cash (Repurchase) of Equity
- -
- -
- -
- -
+ Increase in Capital Stock
- -
- -
- -
- -
+ Decrease in Capital Stock
- -
- -
- -
- -
+ Net Change in LT Investment
- -
-160
98
-103
+ Dec in LT Investment
- -
78
150
106
+ Inc in LT Investment
- -
-238
-53
-209
+ Net Cash From Acq & Div
- -
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
Cash from Investing Activities
-13
-165
97
-104
+ Dividends Paid
- -
- -
- -
- -
+ Net Cash From Debt
- -
- -
- -
- -
+ Cash From Debt
- -
- -
- -
- -
+ Repayments of Debt
- -
- -
- -
- -
+ Other Financing Activities
183
92
27
216
+ Net Cash From Disc Ops
- -
- -
- -
- -
Cash from Financing Activities
183
92
27
216
Effect of Foreign Exchange Rates
- -
- -
- -
- -
Net Changes in Cash
70
-186
6
-18
EBITDA
-120
-129
-130
-156
EBITDA Margin (%)
- -
-12,394.5
-2,907.65
-5,250.17
Free Cash Flow
-113
-118
-118
-131
Net Cash Paid for Acquisitions
- -
- -
- -
- -
Free Cash Flow to Firm
- -
- -
- -
- -
Free Cash Flow to Equity
- -
-123
-119
-130
Free Cash Flow per Basic Share
-4.1
-1.19
-4.29
-4.74
Price/Free Cash Flow
- -
- -
- -
- -
Cash Flow to Net Income
0.8
0.9
0.91
0.87
Capital Expenditures
-13
-5
-1
-1